Intelligent polymerized crystalline colloidal array carbohydrate sensors

• US 20030027240A1
• Filed: 07/01/2002
• Published: 02/06/2003
• Est. Priority Date: 11/06/1996
• Status: Active Grant

• Current Assignee: University Of Pittsburgh (University of Pittsburgh of The Commonwealth System of Higher Education)
• Original Assignee: University Of Pittsburgh (University of Pittsburgh of The Commonwealth System of Higher Education)
• Inventors: Asher, Sanford A., Lednev, Igor K., Wilcox, Craig, Sharma, Anjal C., Alexeev, Vladimir L.
• Granted Patent: US 7,105,352 B2
• Time in Patent Office: Days
• US Class Current: 435/25
• CPC Class Codes: B01J 13/00 Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
• CPC Class Codes: B01J 13/0065 containing an organic phase
• CPC Class Codes: G01J 3/18 using diffraction elements, e.g. grating gratings per se G02B
• CPC Class Codes: G01N 21/4788 Diffraction for sizing particles G01N15/0205
• CPC Class Codes: G01N 21/77 by observing the effect on a chemical indicator
• CPC Class Codes: G01N 31/222 for investigating moisture content
• CPC Class Codes: G02B 26/002 the movement or the deformation controlling the frequency of light, e.g. by Doppler effect
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]
• CPC Class Codes: Y10T 436/144444 Glucose

Abstract

The present invention is related to glucose sensors that are capable of detecting the concentration or level of glucose in a solution or fluid having either low or high ionic strength. The glucose sensors of the present invention comprise a polymerized crystalline colloidal array (PCCA) and a molecular recognition component capable of responding to glucose. The molecular recognition component may be a boronic acid, such as a phenylboronic acid, glucose oxidase, a combination of phenylboronic acid and poly(ethylene)glycol or crown ether, or another component capable of detecting glucose in various fluids and solutions. The glucose sensors of the present invention may be useful in the development of noninvasive or minimally invasive in vivo glucose sensors for patients having diabetes mellitus.

Claims

1. A carbohydrate sensor comprising a polymerized crystalline colloidal array (PCCA) and a molecular recognition component capable of detecting said carbohydrate.

2. The sensor of claim 1, wherein the carbohydrate is glucose.

3. The sensor of claim 2, wherein the molecular recognition component is selected from the group consisting of glucose oxidase (GOD), dihydroxides of boron, barium, calcium, magnesium, and strontium, and boronic acid derivatives.

4. The sensor of claim 3, wherein the molecular recognition component is a boronic acid derivative selected from the group consisting of phenylboronic acid, p-nitrophenylboronic acid, 4-methoxyphenylboronic acid, α

-naphthylboronic acid, 4-aminomethyl-2-N,N′

-dimethylaminomethylphenylboronic acid, 3-fluoro-4-aminophenylboronic acid, and boronic acid derivatives having a pKa less than 7.

5. The sensor of claim 3, further comprising poly(ethylene)glycol or a crown ether.

6. The sensor of claim 1, wherein the crystalline colloidal array is polymerized in a hydrogel, and wherein the hydrogel undergoes a volume change in response to the carbohydrate.

7. The glucose sensor of claim 6, wherein the crystalline colloidal array has a lattice spacing that changes when said volume of said hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change.

8. A method for detecting the concentration of a carbohydrate in a solution comprising:

preparing a carbohydrate sensor comprising a crystalline colloidal array polymerized in a hydrogel, wherein the hydrogel undergoes a volume change in response to the carbohydrate, and wherein said crystalline colloidal array has a lattice spacing that changes when the volume of the hydrogel changes, thereby causing the diffracted wavelength of the crystalline colloidal array to change;

contacting said polymerized crystalline colloidal array with said solution;

measuring the diffracted wavelength of said crystalline colloidal array before and after exposure to said solution; and

comparing the change in diffracted wavelength measurements before and after exposure to determine the concentration of the carbohydrate in said solution.

9. The method of claim 8, wherein said solution may be either a high ionic strength solution or a low ionic strength solution.

10. The method of claim 8, wherein said solution is blood, human tear fluid, artificial tear fluid, interstitial fluid, a fermentation solution, or another bodily fluid.

11. The method of claim 8, wherein the presence of the carbohydrate is determined by inspection of the diffracted wavelength by the polymerized crystalline colloidal array both before and after exposure to said solution, wherein the diffracted wavelength indicates concentration of the carbohydrate.

12. The method of claim 11, including employing the use of a detection device selected from the group consisting of a spectrometer or a spectrophotometer to determine said diffracted wavelength change.

13. The method of claim 11, including employing the unassisted human eye to determine said diffracted wavelength changes, wherein such a change is detectable by a change in color of the carbohydrate sensor.

14. The method of claim 8, wherein the carbohydrate is glucose.

15. The method of claim 8, wherein said carbohydrate sensor preparation step includes the steps of:

(a) allowing charged colloidal particles to self-assemble into a crystalline colloidal array;

(b) adding a first comonomer that is a gel monomer, a crosslinking agent, a molecular recognition component and a polymerization initiator to a medium comprising said crystalline colloidal array; and

(c) polymerizing the mixture of step b) to form a crystalline colloidal array polymerized in a hydrogel.

16. The method of claim 15, wherein the molecular recognition component is selected from the group consisting of glucose oxidase (GOD), dihydroxides of boron, barium, calcium, magnesium, and strontium, and boronic acid derivatives.

17. The method of claim 16, wherein the molecular recognition component is a boronic acid derivative selected from the group consisting of phenylboronic acid, p-nitrophenylboronic acid, 4-methoxyphenylboronic acid, α

-naphthylboronic acid, 4-aminomethyl-2-N,N′

-dimethylaminomethylphenylboronic acid, 3-fluoro-4-aminophenylboronic acid, and boronic acid derivatives having a pKa less than 7.

18. The method of claim 16, further comprising adding poly(ethylene)glycol or a crown ether.

19. The method of claim 17, wherein the molecular recognition component comprises 3-fluoro-4-aminophenylboronic acid and poly(ethylene)glycol.

20. The method of claim 15, further comprising employing a gel selected from the group consisting of acrylamide gels, purified agarose gels, N-vinylpyrolidone gels, and methacrylate gels.

21. The method of claim 15, wherein the crosslinking agent is selected from the group consisting of N,N′

-methylenebisacrylamide, methylenebismethacrylamide, and ethyleneglycol-dimethacrylate.

22. The method of claim 15, wherein the charged colloidal particles are selected from the group consisting of colloidal polystyrene, polymethylmethacrylate, silicon dioxide, aluminum oxide, polytetrafluoroethylene and poly N-isopropylacrylamide.

23. A contact lens comprising a carbohydrate sensor, which comprises a polymerized crystalline colloidal array (PCCA) and a molecular recognition component capable of detecting said carbohydrate.

24. The contact lens of claim 23, wherein said carbohydrate is glucose.

25. The contact lens of claim 23, wherein said molecular recognition component is selected from the group consisting of glucose oxidase (GOD), dihydroxides of boron, barium, calcium, magnesium, and strontium, and boronic acid derivatives.

26. The contact lens of claim 25, wherein the molecular recognition component is a boronic acid derivative selected from the group consisting of phenylboronic acid, p-nitrophenylboronic acid, 4-methoxyphenylboronic acid, a-naphthylboronic acid, 4-aminomethyl-2-N,N′

-dimethylaminomethylphenylboronic acid, 3-fluoro-4-aminophenylboronic acid, and boronic acid derivatives having a pKa less than 7.

27. An optical insert comprising a carbohydrate sensor, which comprises a polymerized crystalline colloidal array (PCCA) and a molecular recognition component capable of detecting said carbohydrate.

28. The optical insert of claim 27, wherein said carbohydrate is glucose.

29. The optical insert of claim 28, wherein said insert may be inserted under the lower eyelid of a patient in order to determine the level of the carbohydrate in the tear fluid of the wearer of said optical insert.

30. The optical insert of claim 29, wherein the molecular recognition component is selected from the group consisting of glucose oxidase (GOD), dihydroxides of boron, barium, calcium, magnesium, and strontium, and boronic acid derivatives.

31. The optical insert of claim 30, wherein the molecular recognition component is a boronic acid derivative selected from the group consisting of phenylboronic acid, p-nitrophenylboronic acid, 4-methoxyphenylboronic acid, α

-naphthylboronic acid, 4-aminomethyl-2-N,N′

-dimethylaminomethylphenylboronic acid, 3-fluoro-4-aminophenylboronic acid, and boronic acid derivatives having a pK_a less than 7.

32. The optical insert of claim 30, further comprising poly(ethylene)glycol or a crown ether.

33. A subcutaneous implant comprising a carbohydrate sensor, which comprises a biocompatible polymerized crystalline colloidal array (PCCA) and a molecular recognition component cable of detecting said carbohydrate.

34. The implant of claim 33, wherein said carbohydrate is glucose.

35. The implant of claim 34, wherein said molecular recognition component is selected from the group consisting of glucose oxidase (GOD), dihydroxides of boron, barium, calcium, magnesium, and strontium, and boronic acid derivatives.

36. The implant of claim 35, wherein the molecular recognition component is a boronic acid derivative selected from the group consisting of phenylboronic acid, p-nitrophenylboronic acid, 4-methoxyphenylboronic acid, α

-naphthylboronic acid, 4-aminomethyl-2-N,N′

-dimethylaminomethylphenylboronic acid, 3-fluoro-4-aminophenylboronic acid, and boronic acid derivatives having a pKa less than 7.

37. The implant of claim 35 further comprising poly(ethylene)glycol or a crown ether.